They are both name brands and quite expensive
GLP-1 medications, like semaglutide, slow digestion and curb appetite, which can lead to eating less overall
In January 2026, Novo Nordisk, the makers of Ozempic (semaglutide), released the drug as daily oral pill
Even if semaglutide reduces cravings, a person may still need help with: Managing stress without drinking Understanding emotional triggers Treating anxiety, depression, or trauma Rebuilding trust with loved ones Creating sober routines Managing social pressure Treating withdrawal risk safely Staying connected when isolation feels easier Medication can support recovery, but it cannot replace the human work of healing
21 Given this critical findings, The ADA advises using GLP-1 RAs to treat type 2 diabetes in adults with MASH, citing histological benefits demonstrated in the mentioned phase 2 randomized controlled trials